FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to medicine, namely to obstetrics. Sample of ischemia/reperfusion is performed for women with chronic hypertension at 22-37 weeks of gestation. The ratio of the forearm tissues oxygenation level is determined after the completion of sample to the original level of oxygenation. If the value of index is equal to 0.93 or more, pre-eclampsia joining is diagnosed.
EFFECT: invention improves the accuracy of pre-eclampsia joining determination for pregnant women with chronic hypertension, and also helps to timely identify the tactics of pregnancy monitoring and carry out activities aimed at treatment of the identified disease.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSTICS OF PREECLAMPSIA ATTACHMENT IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2016 |
|
RU2652447C1 |
| DIAGNOSTIC TECHNIQUE FOR PREECLAMPSIA IN PREGNANT WOMEN SUFFERING CHRONIC ARTERIAL HYPERTENSION | 2014 |
|
RU2561060C1 |
| METHOD OF DIAGNOSING SEVERE PREECLAMPSIA | 2015 |
|
RU2587781C1 |
| METHOD FOR DIAGNOSING SEVERITY OF PREECLAMPSIA WITH UNDERLYING CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2815220C1 |
| METHOD OF DIAGNOSTICS OF SEVERITY OF PRE-ECLAMPSIA ON THE BACKGROUND OF CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2804645C1 |
| METHOD FOR PREDICTION OF CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2023 |
|
RU2819655C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
| METHOD OF PREDICTING PERINATAL PATHOLOGY IN NEWBORN BABIES | 2011 |
|
RU2472438C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTENSIVE DISORDERS DURING PREGNANCY | 2010 |
|
RU2444280C2 |
| METHOD FOR PREDICTING CEREBRAL ISCHEMIA IN NEWBORNS BORN TO MOTHERS WITH PREECLAMPSIA | 2021 |
|
RU2777225C1 |
